Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN ) 0.6432 +0.0292 (+4.76%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 137,376 Open 0.6108 Bid (Size) 0.6012 (10) Ask (Size) 0.6750 (17) Prev. Close 0.6140 Today's Range 0.5810 - 0.6999 52wk Range 0.4180 - 21.09 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities August 09, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback July 11, 2024 From Tevogen Bio Inc Via GlobeNewswire Performance YTD -93.57% -93.57% 1 Month -8.10% -8.10% 3 Month -35.68% -35.68% 6 Month -93.57% -93.57% 1 Year -93.57% -93.57% More News Read More Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian July 10, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities June 26, 2024 From Tevogen Bio Inc Via GlobeNewswire Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility July 08, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances June 25, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference June 18, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen Bio Set to Join Russell 3000® Index June 12, 2024 From Tevogen Bio Inc Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 12, 2024 Via Benzinga Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts June 11, 2024 From Tevogen Bio Inc Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session June 07, 2024 Via Benzinga CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event June 07, 2024 From Tevogen Bio Inc Via GlobeNewswire Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event June 06, 2024 From Tevogen Bio Inc Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session June 06, 2024 Via Benzinga Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2 June 06, 2024 From Tevogen Bio Inc Via GlobeNewswire TVGN Stock Earnings: Tevogen Bio Holdings Reported Results for Q1 2024 May 30, 2024 Via InvestorPlace Tevogen Bio Reports First Quarter 2024 Financial Results May 29, 2024 From Tevogen Bio Inc Via GlobeNewswire Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket May 21, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 21, 2024 Via Benzinga Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives May 16, 2024 From Tevogen Bio Inc Via GlobeNewswire Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 13, 2024 Via Benzinga Why Tevogen Bio Holdings Stock Is Moving Higher Today May 13, 2024 Via Benzinga Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today? May 13, 2024 Via InvestorPlace Why Is Safe & Green Development (SGD) Stock Down 5% Today? May 13, 2024 Via InvestorPlace Topics Regulatory Compliance Exposures Legal Regulatory Why Is AC Immune (ACIU) Stock Up 45% Today? May 13, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
